
Vandetanib Tablets
Form: Tablets
Strength: 300 mg
Reference Brands: Caprelsa
Category: Orphan Drugs
Vandetanib tablets, marketed as Caprelsa, are approved in the US by the FDA and in the EU via EMA for treating medullary thyroid carcinoma. Regulatory approval requires a comprehensive dossier, including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports rapid approval, safe patient use, and worldwide availability to improve outcomes in advanced thyroid cancer management globally. Mitul agarwal Riluzole: Forms, Brands, and Strengths in EU and US OpenAI GPT-4o mini Riluzole: Forms, Brands, and Strengths in EU and US Forms: Oral Tablets: The primary form for use in amyotrophic lateral sclerosis (ALS). Brands & Strengths: US: Rilutek: (brand name) Strengths: 50 mg tablets EU: Riluzole: (generic and branded options) Strengths: Similar 50 mg tablets Summary: Riluzole is available as 50 mg oral tablets in both the US and EU, supported for slowing ALS progression. Generic formulations and branded Rilutek ensure broad access, supporting disease management in ALS patients worldwide with regional regulatory compliance.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Galsulfase IV
Strength: 1mg/ml
Form: Lyophilized powder for IV
Reference Brands: Vimizim®(US & EU)
View Details Get EnquiryAlglucosidase Alfa IV
Strength: 50 mg/vial
Form: Lyophilized powder
Reference Brands: Lumizyme®(US & EU)
View Details Get EnquiryNitisinone tablets
Strength: 2 mg and 5 mg
Form: Tablets
Reference Brands: Orfadin®
View Details Get EnquiryTreprostinil IV or SC
Strength: 2 mg (0.1 mg/mL), 4 mg (0.2 mg/mL), 8 mg (0.4 mg/mL), 20 mg (1 mg/mL), 50 mg (2.5 mg/mL), 100 mg (5 mg/mL), 200 mg (10 mg/mL), or 400 mg (20 mg/mL)
Form: SC or Intravenous (IV)
Reference Brands: Remodulin®(US & EU)
View Details Get Enquiry